{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T10:48:13Z","timestamp":1767178093379,"version":"build-2238731810"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1005948","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T00:00:00Z","timestamp":1516924800000}}],"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T00:00:00Z","timestamp":1516060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1052304"],"award-info":[{"award-number":["APP1052304"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH54137"],"award-info":[{"award-number":["MH54137"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA022413"],"award-info":[{"award-number":["DA022413"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1005948","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T13:25:43Z","timestamp":1516109143000},"page":"e1005948","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors"],"prefix":"10.1371","volume":"14","author":[{"given":"Ravi Kumar","family":"Verma","sequence":"first","affiliation":[]},{"given":"Ara M.","family":"Abramyan","sequence":"additional","affiliation":[]},{"given":"Mayako","family":"Michino","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2428-0487","authenticated-orcid":true,"given":"R. Benjamin","family":"Free","sequence":"additional","affiliation":[]},{"given":"David R.","family":"Sibley","sequence":"additional","affiliation":[]},{"given":"Jonathan A.","family":"Javitch","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7361-7875","authenticated-orcid":true,"given":"J. Robert","family":"Lane","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4137-096X","authenticated-orcid":true,"given":"Lei","family":"Shi","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2018,1,16]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nrd2518","article-title":"Structural diversity of G protein-coupled receptors and significance for drug discovery","volume":"7","author":"MC Lagerstrom","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"JM Beaulieu","year":"2011","journal-title":"Pharmacol Rev"},{"key":"ref3","first-page":"4","article-title":"Current perspectives on selective dopamine D-3 receptor antagonists as pharmacotherapeutics for addictions and related disorders","volume":"1187","author":"CA Heidbreder","year":"2010","journal-title":"Addiction Reviews 2"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"C Missale","year":"1998","journal-title":"Physiol Rev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev-pharmtox-032112-135923","article-title":"Structure-function of the G protein-coupled receptor superfamily","volume":"53","author":"V Katritch","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bph.12906","article-title":"Dopamine receptors\u2014IUPHAR Review 13","volume":"172","author":"JM Beaulieu","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1124\/pr.114.009944","article-title":"What Can Crystal Structures of Aminergic Receptors Tell Us about Designing Subtype-Selective Ligands?","volume":"67","author":"M Michino","year":"2015","journal-title":"Pharmacological Reviews"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tips.2012.10.003","article-title":"Bridging the gap: bitopic ligands of G-protein-coupled receptors","volume":"34","author":"JR Lane","year":"2013","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1124\/mol.110.065755","article-title":"The Tetrahydroisoquinoline Derivative SB269,652 Is an Allosteric Antagonist at Dopamine D-3 and D-2 Receptors","volume":"78","author":"E Silvano","year":"2010","journal-title":"Molecular Pharmacology"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nchembio.1593","article-title":"A new mechanism of allostery in a G protein-coupled receptor dimer","volume":"10","author":"JR Lane","year":"2014","journal-title":"Nature Chemical Biology"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1021\/acs.jmedchem.6b01688","article-title":"Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D3 Receptor (D3R)","volume":"60","author":"V Kumar","year":"2017","journal-title":"J Med Chem"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.euroneuro.2014.11.013","article-title":"Investigation of the binding and functional properties of extended length D3 dopamine receptor-selective antagonists","volume":"25","author":"CA Furman","year":"2015","journal-title":"European Neuropsychopharmacology"},{"key":"ref13","first-page":"366","article-title":"[19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors.","volume":"25","author":"JA Ballesteros","year":"1995"},{"issue":"13","key":"ref14","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1021\/acs.jmedchem.5b00581","article-title":"Structure-activity study of N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-ind ole-2-carboxamide (SB269652), a bitopic ligand that acts as a negative allosteric modulator of the dopamine D2 receptor","volume":"58","author":"J Shonberg","year":"2015","journal-title":"J Med Chem"},{"issue":"17","key":"ref15","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.1021\/acs.jmedchem.5b00585","article-title":"Discovery of a Novel Class of Negative Allosteric Modulator of the Dopamine D2 Receptor Through Fragmentation of a Bitopic Ligand","volume":"58","author":"SN Mistry","year":"2015","journal-title":"J Med Chem"},{"issue":"17","key":"ref16","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/emboj.2008.153","article-title":"Dopamine D2 receptors form higher order oligomers at physiological expression levels","volume":"27","author":"W Guo","year":"2008","journal-title":"The EMBO journal"},{"key":"ref17","article-title":"An Introduction to Markov State Models and Their Application to Long Timescale Molecular Simulation","author":"GR Bowman","year":"2013"},{"issue":"17","key":"ref18","doi-asserted-by":"crossref","DOI":"10.1063\/1.3565032","article-title":"Markov models of molecular kinetics: Generation and validation","volume":"134","author":"JH Prinz","year":"2011","journal-title":"Journal of Chemical Physics"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"RA Laskowski","year":"2011","journal-title":"J Chem Inf Model"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1021\/acs.jmedchem.6b01148","article-title":"Toward Understanding the Structural Basis of Partial Agonism at the Dopamine D3 Receptor","volume":"60","author":"M Michino","year":"2017","journal-title":"Journal of Medicinal Chemistry"},{"issue":"15","key":"ref21","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1021\/jm300482h","article-title":"Molecular Determinants of Selectivity and Efficacy at the Dopamine D3 Receptor","volume":"55","author":"AH Newman","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.bbamem.2016.01.010","article-title":"Computational approaches to detect allosteric pathways in transmembrane molecular machines","volume":"1858","author":"S Stolzenberg","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1124\/mol.113.087833","article-title":"A Single Glycine in Extracellular Loop 1 Is the Critical Determinant for Pharmacological Specificity of Dopamine D2 and D3 Receptors","volume":"84","author":"M Michino","year":"2013","journal-title":"Molecular Pharmacology"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1021\/acs.jmedchem.6b01875","article-title":"Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism","volume":"60","author":"A Bonifazi","year":"2017","journal-title":"J Med Chem"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1021\/jm501889t","article-title":"Molecular Determinants of Biased Agonism at the Dopamine D2 Receptor","volume":"58","author":"D Weichert","year":"2015","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2760","article-title":"Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders","volume":"8","author":"PJ Conn","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"35","key":"ref27","doi-asserted-by":"crossref","first-page":"18210","DOI":"10.1074\/jbc.M116.729517","article-title":"Endogenous N-terminal Domain Cleavage Modulates alpha1D-Adrenergic Receptor Pharmacodynamics","volume":"291","author":"TS Kountz","year":"2016","journal-title":"J Biol Chem"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1124\/mol.113.089086","article-title":"Role of the N-terminal region in G protein-coupled receptor functions: negative modulation revealed by 5-HT2B receptor polymorphisms","volume":"85","author":"A Belmer","year":"2014","journal-title":"Mol Pharmacol"},{"issue":"18","key":"ref29","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1111\/bph.12785","article-title":"Buprenorphine signalling is compromised at the N40D polymorphism of the human mu opioid receptor in vitro","volume":"171","author":"A Knapman","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"9","key":"ref30","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1111\/bph.13047","article-title":"A6V polymorphism of the human mu-opioid receptor decreases signalling of morphine and endogenous opioids in vitro","volume":"172","author":"A Knapman","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"6007","key":"ref31","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1126\/science.1197410","article-title":"Structure of the human dopamine D3 receptor in complex with a D2\/D3 selective antagonist","volume":"330","author":"EY Chien","year":"2010","journal-title":"Science"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"W Sherman","year":"2006","journal-title":"J Med Chem"},{"issue":"41","key":"ref33","doi-asserted-by":"crossref","first-page":"8618","DOI":"10.1039\/C5CC02204E","article-title":"Structural basis for Na(+)-sensitivity in dopamine D2 and D3 receptors","volume":"51","author":"M Michino","year":"2015","journal-title":"Chem Commun (Camb)"},{"issue":"18","key":"ref34","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1021\/jp973084f","article-title":"All-atom empirical potential for molecular modeling and dynamics studies of proteins","volume":"102","author":"AD MacKerell","year":"1998","journal-title":"J Phys Chem B"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/jcc.20065","article-title":"Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations","volume":"25","author":"AD Mackerell Jr.","year":"2004","journal-title":"J Comput Chem"},{"issue":"9","key":"ref36","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1021\/ct300400x","article-title":"Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone phi, psi and side-chain chi(1) and chi(2) dihedral angles","volume":"8","author":"RB Best","year":"2012","journal-title":"J Chem Theory Comput"},{"issue":"23","key":"ref37","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.1021\/jp101759q","article-title":"Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types","volume":"114","author":"JB Klauda","year":"2010","journal-title":"J Phys Chem B"},{"issue":"8","key":"ref38","doi-asserted-by":"crossref","DOI":"10.1021\/ct4003477","article-title":"Automated Force Field Parameterization for Non-Polarizable and Polarizable Atomic Models Based on Ab Initio Target Data","volume":"9","author":"L Huang","year":"2013","journal-title":"J Chem Theory Comput"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"K Vanommeslaeghe","year":"2010","journal-title":"J Comput Chem"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1063\/1.470648","article-title":"Constant pressure molecular dynamics simulation: The Langevin piston method","volume":"103","author":"SE Feller","year":"1995","journal-title":"J Chem Phys"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1021\/acs.jctc.5b00743","article-title":"PyEMMA 2: A Software Package for Estimation, Validation, and Analysis of Markov Models","volume":"11","author":"MK Scherer","year":"2015","journal-title":"J Chem Theory Comput"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"015102","DOI":"10.1063\/1.4811489","article-title":"Identification of slow molecular order parameters for Markov model construction","volume":"139","author":"G Perez-Hernandez","year":"2013","journal-title":"J Chem Phys"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1021\/ct300878a","article-title":"Improvements in Markov State Model Construction Reveal Many Non-Native Interactions in the Folding of NTL9","volume":"9","author":"CR Schwantes","year":"2013","journal-title":"J Chem Theory Comput"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1137\/110858616","article-title":"A Variational Approach to Modeling Slow Processes in Stochastic Dynamical Systems","volume":"11","author":"F No\u00e9","year":"2013","journal-title":"Multiscale Modeling & Simulation"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/ct4009156","article-title":"Variational Approach to Molecular Kinetics","volume":"10","author":"F Nuske","year":"2014","journal-title":"J Chem Theory Comput"},{"issue":"12","key":"ref46","doi-asserted-by":"crossref","first-page":"124105","DOI":"10.1063\/1.4916292","article-title":"Variational cross-validation of slow dynamical modes in molecular kinetics","volume":"142","author":"RT McGibbon","year":"2015","journal-title":"J Chem Phys"},{"key":"ref47","article-title":"The Isomeric Preference of an Atypical Dopamine Transporter Inhibitor Contributes to Its Selection of the Transporter Conformation","author":"AM Abramyan","year":"2017","journal-title":"ACS Chem Neurosci"},{"issue":"16","key":"ref48","doi-asserted-by":"crossref","first-page":"164113","DOI":"10.1063\/1.4801325","article-title":"Efficient Bayesian estimation of Markov model transition matrices with given stationary distribution","volume":"138","author":"B Trendelkamp-Schroer","year":"2013","journal-title":"J Chem Phys"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11634-013-0134-6","article-title":"Fuzzy spectral clustering by PCCA plus: application to Markov state models and data classification","volume":"7","author":"S Roblitz","year":"2013","journal-title":"Advances in Data Analysis and Classification"},{"issue":"20","key":"ref50","doi-asserted-by":"crossref","first-page":"204909","DOI":"10.1063\/1.2116947","article-title":"Error analysis and efficient sampling in Markovian state models for molecular dynamics","volume":"123","author":"N Singhal","year":"2005","journal-title":"J Chem Phys"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1005948","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T00:00:00Z","timestamp":1516924800000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1005948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T10:50:37Z","timestamp":1719744637000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1005948"}},"subtitle":[],"editor":[{"given":"Donald","family":"Jacobs","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2018,1,16]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1005948","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,16]]}}}